Lianhua Qingke Tablet in severe pneumonia: Clinical efficacy and immunoregulatory mechanisms
LHQK demonstrates therapeutic efficacy in severe pneumonia by maintaining structural integrity, suppressing cytokine storms, enhancing intrinsic immunity, reversing T cell exhaustion, and correcting lung immune disorders. These findings significantly substantiate LHQK's potential clinical application in severe pneumonia treatment.
Authors
- Zhenhua Jia (ORCID: https://orcid.org/0000-0001-5132-1099)
- Peipei Jin (ORCID: https://orcid.org/0000-0002-5787-1777)
- Hui Qi (ORCID: https://orcid.org/0009-0007-9934-7096)
- Qingling Feng (ORCID: https://orcid.org/0000-0003-1288-300X)
- Yadong Yuan
- Yunlong Hou (ORCID: https://orcid.org/0000-0002-6989-8221)
- Caiyun Yuan
- Le Wang (ORCID: https://orcid.org/0000-0002-3172-2423)
- Shiwei Kang
- Yuanyuan Zhang (ORCID: https://orcid.org/0000-0002-6087-0652)
- Yan Ma (ORCID: https://orcid.org/0000-0003-1510-3232)
- Jing Zhao (ORCID: https://orcid.org/0000-0002-0345-867X)
Institutions
- Hebei Medical University (CN)
- Third Hospital of Hebei Medical University (CN)
- Second Hospital of Hebei Medical University (CN)
- Hebei Yiling Hospital (CN)
- Hebei University of Chinese Medicine (CN)
- Hebei Academy of Sciences (CN)
Publication Details
- Journal
- Journal of Ethnopharmacology
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1016/j.jep.2025.119420
- Citations
- 4
- Primary Topic
- Mycobacterium research and diagnosis
- Type
- article
- Field-Weighted Citation Impact
- 5.42